Efficacy of curcumin in the treatment of oral submucous fibrosis: a Meta-analysis.
- Author:
Jin-Cai GUO
1
;
Hui XIE
1
;
Hao WU
1
;
Tie-Jun TONG
2
Author Information
- Publication Type:Meta-Analysis
- Keywords: Meta-analysis; curcumin; evidence-based medicine; oral submucous fibrosis
- MeSH: Curcumin; Databases, Factual; Humans; Oral Submucous Fibrosis/drug therapy*; Randomized Controlled Trials as Topic; Treatment Outcome
- From: West China Journal of Stomatology 2021;39(2):195-202
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:This study was performed to review the efficacy of curcumin in the treatment of oral submucous fibrosis systematically.
METHODS:We searched seven databases, including Web of Science, PubMed, EBSCO, The Cochrane Library, CNKI, WanFang Data, and VIP, to obtain randomized controlled trials related to the treatment of oral submucous fibrosis by curcumin. Each database was searched from inception to 30 June 2019. RevMan 5.3 software was used for the meta-analysis.
RESULTS:Six randomized controlled trials involving 350 patients were included in this study. Meta-analysis showed that curcumin can increase the maximal mouth opening and improve burning sensation compared with placebo treatment. Curcumin was not as effective as the controls in achieving maximal mouth opening after 1 month of treatment. However, no statistically significant difference was observed between the treatments from 2 months to 6 months. Curcumin significantly improved burning sensation compared with the controls after 3 months of treatment. No statistically significant diffe-rence in burning sensation was observed between the curcumin and control groups after 1, 2, and 6 months of treatment.
CONCLUSIONS:The current evidence shows that curcumin is an effective treatment for improving maximal mouth opening and burning sensation in patients with oral submucous fibrosis. Given the limited number and low quality of the included studies, however, more high-quality studies are needed to verify these findings.
